Pediatric Vaccines Market Size, Share, Growth, and Industry Analysis, By Type (Diphtheria, Influenza, Hepatitis, Pneumococcal Diseases, Meningococcal Diseases, Others), By Application (Newborn, Infant, Child, Dolescent), Regional Insights and Forecast From 2026 To 2035

Detailed TOC of Global Pediatric Vaccines Market Outlook 2022

1 Pediatric Vaccines Market Overview
1.1 Product Overview and Scope of Pediatric Vaccines
1.2 Pediatric Vaccines Segment by Type
1.2.1 Global Pediatric Vaccines Sales Growth Rate Comparison by Type (2021-2035)
1.2.2 Diphtheria
1.2.3 Influenza
1.2.4 Hepatitis
1.2.5 Pneumococcal Diseases
1.2.6 Meningococcal Diseases
1.2.7 Others
1.3 Pediatric Vaccines Segment by Application
1.3.1 Global Pediatric Vaccines Sales Comparison by Application: (2021-2035)
1.3.2 Newborn
1.3.3 Infant
1.3.4 Child
1.3.5 Dolescent
1.4 Global Pediatric Vaccines Market Size Estimates and Forecasts
1.4.1 Global Pediatric Vaccines Revenue 2016-2035
1.4.2 Global Pediatric Vaccines Sales 2016-2035
1.4.3 Pediatric Vaccines Market Size by Region: 2016 Versus 2021 Versus 2035

2 Pediatric Vaccines Market Competition by Manufacturers
2.1 Global Pediatric Vaccines Sales Market Share by Manufacturers (2016-2021)
2.2 Global Pediatric Vaccines Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Pediatric Vaccines Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Pediatric Vaccines Manufacturing Sites, Area Served, Product Type
2.5 Pediatric Vaccines Market Competitive Situation and Trends
2.5.1 Pediatric Vaccines Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Pediatric Vaccines Players Market Share by Revenue
2.5.3 Global Pediatric Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Pediatric Vaccines Retrospective Market Scenario by Region
3.1 Global Pediatric Vaccines Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Pediatric Vaccines Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Pediatric Vaccines Market Facts & Figures by Country
3.3.1 North America Pediatric Vaccines Sales by Country
3.3.2 North America Pediatric Vaccines Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Pediatric Vaccines Market Facts & Figures by Country
3.4.1 Europe Pediatric Vaccines Sales by Country
3.4.2 Europe Pediatric Vaccines Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Pediatric Vaccines Market Facts & Figures by Region
3.5.1 Asia Pacific Pediatric Vaccines Sales by Region
3.5.2 Asia Pacific Pediatric Vaccines Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Pediatric Vaccines Market Facts & Figures by Country
3.6.1 Latin America Pediatric Vaccines Sales by Country
3.6.2 Latin America Pediatric Vaccines Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.6.6 Colombia
3.7 Middle East and Africa Pediatric Vaccines Market Facts & Figures by Country
3.7.1 Middle East and Africa Pediatric Vaccines Sales by Country
3.7.2 Middle East and Africa Pediatric Vaccines Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Pediatric Vaccines Historic Market Analysis by Type
4.1 Global Pediatric Vaccines Sales Market Share by Type (2016-2021)
4.2 Global Pediatric Vaccines Revenue Market Share by Type (2016-2021)
4.3 Global Pediatric Vaccines Price by Type (2016-2021)

5 Global Pediatric Vaccines Historic Market Analysis by Application
5.1 Global Pediatric Vaccines Sales Market Share by Application (2016-2021)
5.2 Global Pediatric Vaccines Revenue Market Share by Application (2016-2021)
5.3 Global Pediatric Vaccines Price by Application (2016-2021)

6 Key Companies Profiled
6.1 GlaxoSmithKline
6.1.1 GlaxoSmithKline Corporation Information
6.1.2 GlaxoSmithKline Description and Business Overview
6.1.3 GlaxoSmithKline Pediatric Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.1.4 GlaxoSmithKline Pediatric Vaccines Product Portfolio
6.1.5 GlaxoSmithKline Recent Developments/Updates
6.2 Merck
6.2.1 Merck Corporation Information
6.2.2 Merck Description and Business Overview
6.2.3 Merck Pediatric Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Merck Pediatric Vaccines Product Portfolio
6.2.5 Merck Recent Developments/Updates
6.3 Pfizer
6.3.1 Pfizer Corporation Information
6.3.2 Pfizer Description and Business Overview
6.3.3 Pfizer Pediatric Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Pfizer Pediatric Vaccines Product Portfolio
6.3.5 Pfizer Recent Developments/Updates
6.4 Sanofi
6.4.1 Sanofi Corporation Information
6.4.2 Sanofi Description and Business Overview
6.4.3 Sanofi Pediatric Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Sanofi Pediatric Vaccines Product Portfolio
6.4.5 Sanofi Recent Developments/Updates
6.5 AstraZeneca
6.5.1 AstraZeneca Corporation Information
6.5.2 AstraZeneca Description and Business Overview
6.5.3 AstraZeneca Pediatric Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.5.4 AstraZeneca Pediatric Vaccines Product Portfolio
6.5.5 AstraZeneca Recent Developments/Updates
6.6 Novartis
6.6.1 Novartis Corporation Information
6.6.2 Novartis Description and Business Overview
6.6.3 Novartis Pediatric Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Novartis Pediatric Vaccines Product Portfolio
6.6.5 Novartis Recent Developments/Updates
6.7 Takeda Pharmaceutical
6.6.1 Takeda Pharmaceutical Corporation Information
6.6.2 Takeda Pharmaceutical Description and Business Overview
6.6.3 Takeda Pharmaceutical Pediatric Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Takeda Pharmaceutical Pediatric Vaccines Product Portfolio
6.7.5 Takeda Pharmaceutical Recent Developments/Updates
6.8 Bavarian Nordic
6.8.1 Bavarian Nordic Corporation Information
6.8.2 Bavarian Nordic Description and Business Overview
6.8.3 Bavarian Nordic Pediatric Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Bavarian Nordic Pediatric Vaccines Product Portfolio
6.8.5 Bavarian Nordic Recent Developments/Updates
6.9 Baxter
6.9.1 Baxter Corporation Information
6.9.2 Baxter Description and Business Overview
6.9.3 Baxter Pediatric Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Baxter Pediatric Vaccines Product Portfolio
6.9.5 Baxter Recent Developments/Updates
6.10 LG Life Sciences
6.10.1 LG Life Sciences Corporation Information
6.10.2 LG Life Sciences Description and Business Overview
6.10.3 LG Life Sciences Pediatric Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.10.4 LG Life Sciences Pediatric Vaccines Product Portfolio
6.10.5 LG Life Sciences Recent Developments/Updates
6.11 Lupin
6.11.1 Lupin Corporation Information
6.11.2 Lupin Pediatric Vaccines Description and Business Overview
6.11.3 Lupin Pediatric Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.11.4 Lupin Pediatric Vaccines Product Portfolio
6.11.5 Lupin Recent Developments/Updates
6.12 S K Chemicals
6.12.1 S K Chemicals Corporation Information
6.12.2 S K Chemicals Pediatric Vaccines Description and Business Overview
6.12.3 S K Chemicals Pediatric Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.12.4 S K Chemicals Pediatric Vaccines Product Portfolio
6.12.5 S K Chemicals Recent Developments/Updates
6.13 Mitsubishi Tanabe Pharma
6.13.1 Mitsubishi Tanabe Pharma Corporation Information
6.13.2 Mitsubishi Tanabe Pharma Pediatric Vaccines Description and Business Overview
6.13.3 Mitsubishi Tanabe Pharma Pediatric Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.13.4 Mitsubishi Tanabe Pharma Pediatric Vaccines Product Portfolio
6.13.5 Mitsubishi Tanabe Pharma Recent Developments/Updates
6.14 Janssen
6.14.1 Janssen Corporation Information
6.14.2 Janssen Pediatric Vaccines Description and Business Overview
6.14.3 Janssen Pediatric Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.14.4 Janssen Pediatric Vaccines Product Portfolio
6.14.5 Janssen Recent Developments/Updates
6.15 Shenzhen Kangtai Biological Products
6.15.1 Shenzhen Kangtai Biological Products Corporation Information
6.15.2 Shenzhen Kangtai Biological Products Pediatric Vaccines Description and Business Overview
6.15.3 Shenzhen Kangtai Biological Products Pediatric Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.15.4 Shenzhen Kangtai Biological Products Pediatric Vaccines Product Portfolio
6.15.5 Shenzhen Kangtai Biological Products Recent Developments/Updates
6.16 Sinovac Biotech
6.16.1 Sinovac Biotech Corporation Information
6.16.2 Sinovac Biotech Pediatric Vaccines Description and Business Overview
6.16.3 Sinovac Biotech Pediatric Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.16.4 Sinovac Biotech Pediatric Vaccines Product Portfolio
6.16.5 Sinovac Biotech Recent Developments/Updates
6.17 Bharat Biotech
6.17.1 Bharat Biotech Corporation Information
6.17.2 Bharat Biotech Pediatric Vaccines Description and Business Overview
6.17.3 Bharat Biotech Pediatric Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.17.4 Bharat Biotech Pediatric Vaccines Product Portfolio
6.17.5 Bharat Biotech Recent Developments/Updates
6.18 Crucell
6.18.1 Crucell Corporation Information
6.18.2 Crucell Pediatric Vaccines Description and Business Overview
6.18.3 Crucell Pediatric Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.18.4 Crucell Pediatric Vaccines Product Portfolio
6.18.5 Crucell Recent Developments/Updates
6.19 Dynavax
6.19.1 Dynavax Corporation Information
6.19.2 Dynavax Pediatric Vaccines Description and Business Overview
6.19.3 Dynavax Pediatric Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.19.4 Dynavax Pediatric Vaccines Product Portfolio
6.19.5 Dynavax Recent Developments/Updates
6.20 Serum Institute of India
6.20.1 Serum Institute of India Corporation Information
6.20.2 Serum Institute of India Pediatric Vaccines Description and Business Overview
6.20.3 Serum Institute of India Pediatric Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.20.4 Serum Institute of India Pediatric Vaccines Product Portfolio
6.20.5 Serum Institute of India Recent Developments/Updates

7 Pediatric Vaccines Manufacturing Cost Analysis
7.1 Pediatric Vaccines Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Pediatric Vaccines
7.4 Pediatric Vaccines Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Pediatric Vaccines Distributors List
8.3 Pediatric Vaccines Customers

9 Pediatric Vaccines Market Dynamics
9.1 Pediatric Vaccines Industry Trends
9.2 Pediatric Vaccines Growth Drivers
9.3 Pediatric Vaccines Market Challenges
9.4 Pediatric Vaccines Market Restraints

10 Global Market Forecast
10.1 Pediatric Vaccines Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Pediatric Vaccines by Type (2022-2035)
10.1.2 Global Forecasted Revenue of Pediatric Vaccines by Type (2022-2035)
10.2 Pediatric Vaccines Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Pediatric Vaccines by Application (2022-2035)
10.2.2 Global Forecasted Revenue of Pediatric Vaccines by Application (2022-2035)
10.3 Pediatric Vaccines Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Pediatric Vaccines by Region (2022-2035)
10.3.2 Global Forecasted Revenue of Pediatric Vaccines by Region (2022-2035)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer